Camber Pharmaceuticals Launches Generic Gralise®

Camber Pharmaceuticals is pleased to announce the addition of Gabapentin Tablets (generic for Gralise®) to its current portfolio. Camber already offers Gabapentin Tablets and Capsules (generic for Neurontin®). Generics for Gralise® and Neurontin® are not interchangeable.
Gabapentin Tablets (generic for Gralise®) are indicated for the management of Postherpetic Neuralgia (PHN).
Gabapentin Tablets (generic for Gralise®) 300 mg and 600 mg are available in 90 count bottles.
To find out more about Gabapentin Tablets, please visit https://www.camberpharma.com/gabapentintablets-gralise
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection